Skip to main content

Table 1 Patient demographics of those undergoing liver transplantation for polycystic liver disease

From: Liver transplantation in adult polycystic liver disease: the Ontario experience

Variable

Total

Male

Female

Number of Transplants

51 (100%)

8 (16%)

43 (84%)

Median age*

54 (46–59)

62 (59–64)

52 (45–56)

Median Waitlist (months)

9.8 (5.5–18.7)

10.2 (7.4–14.1)

9.5 (5–18.8)

Median MELD score at time of transplant

13 (7–22)

22 (17–22)

10 (6–21)

Median (years) follow up

6.3 (12.5)

2.9 (2.2–4.1)

8 (3–13.8)

Orthotopic Liver transplant

46 (90.1%)

8 (15.6%)

38 (74.5%)

Living donor

5 (9.8%)

0 (0%)

5 (9.8%)

Liver transplant alone

29 (56.8%)

1 (1.9%)

28 (54.9%)

Kidney first then liver transplant

15 (29.4%)

3 (5.8%)

12 (23.5%)

Simultaneous Liver-Kidney transplant (SLK)

7 (13.7%)

4 (7.8%)

3 (5.8%)

Median Creatinine \((\upmu\) mol)

101 (80–319)

426 (237–485)

91 (73–184)

Median Hemoglobin (g/L)

116(109–126)

118 (113–127)

116 (109–127)

Median platelet (109/L)*

189 (130–239)

189 (118– 203)

193 (132–240)

Median Bilirubin \(\upmu\) mol*

10 (8–14)

10 (9–11)

10 (7–14)

Median INR*

1.1 (1–1.2)

1.2 (1.15–1.2)

1.1 (1–1.2)

Median Albumin (g/L)*

40 (35–43)

36 (33–40)

40 (35–43)

Death

4 (7.8%)

1 (1.9%)

3 (5.8%)

  1. *Medians expressed as IQR